Colorectal cancer: predicting prognosis for patients and probands using immunohistochemistry
Khurana, V.; Stollman, N.; Rogers, A.I.
American Journal of Gastroenterology 95(10): 2981-2982
2000
ISSN/ISBN: 0002-9270 PMID: 11051382 Document Number: 513020
Document emailed within 1 workday
Related Documents
Hatano, S.; Matsuzawa, T.; Chika, N.; Tajima, Y.; Watanabe, Y.; Fukuchi, M.; Baba, H.; Kumagai, Y.; Ishibashi, K.; Mochiki, E.; Ishida, H. 2014: Is PCi effective in predicting prognosis in the era of oxaliplatin-based chemotherapy in stage IV colorectal cancer with peritoneal dissemination ? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(12): 1692-1694Wei, Y.-s.; Hong, C.-y.; Zhao, C.-x.; Liang, G.-j.; Wang, G.-q.; Zou, X.-c.; Lin, H. 2012: Clinicopathological features and prognosis of colorectal cancer patients with preoperative cancer-related anemia Zhonghua Wei Chang Wai Ke Za Zhi 15(4): 385-387
Hong, R.-x.; Lin, Q.-j.; Luo, J.; Dai, Z.; Wang, W.-n. 2013: Clinical features and prognosis in 104 colorectal cancer patients with bone metastases Zhonghua Zhong Liu Za Zhi 35(10): 787-791
Sanguedolce, R.; Vultaggio, G.; Sanguedolce, F.; Modica, G.; Li Volsi, F.; Diana, G.; Guereio, G.; Bellanca, L.; Rausa, L. 1998: The role of thymidylate synthase levels in the prognosis and the treatment of patients with colorectal cancer Anticancer Research 18(3a): 1515-1520
Liu, H.-l.; Du, X.-h.; Sun, P.-m.; Xiao, C.-h.; Zou, Z.-y.; Xu, Y.-x. 2013: Assessment value of preoperative neutrophil-lymphocyte ratio for the prognosis of patients with colorectal cancer after radical operation Zhonghua Wei Chang Wai Ke Za Zhi 16(8): 723-726
Tokunaga, Y.; Nakagami, M.; Tokuka, A.; Ohsumi, K. 2003: Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: immunohistochemistry using a new monoclonal antibody Anticancer Research 23(2C): 1763-1768
Penault-Llorca, F.; Jacquemier, J.; Le Doussal, V.; Voigt, J.J. 1999: Quality challenge for immunohistochemistry: example of the ERBB-2 status in breast cancer. Group for Evaluation of Prognostic Factors in Immunohistochemistry in Breast Cancer (GEFPICS) Annales de Pathologie 19(4): 280-282
Shao, X.-l.; Han, H.-q.; He, X.-l.; Fu, Q.; Lv, Y.-c.; Liu, G. 2011: Impact of number of retrieved lymph nodes and lymph node ratio on the prognosis in patients with stage Ii and IIi colorectal cancer Zhonghua Wei Chang Wai Ke Za Zhi 14(4): 249-253
Bai, Y.-q.; Liu, X.-j.; Wang, Y.; Ge, F.-j.; Zhao, C.-h.; Fu, Y.-l.; Lin, L.; Xu, J.-m. 2013: Correlation analysis between abundance of K-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer Zhonghua Zhong Liu Za Zhi 35(9): 666-671
Foggi, E.; Carbognani, P. 1993: The value of ploidy in the prognosis of the colorectal cancer Acta Bio-Medica de l'Ateneo Parmense 64(5-6): 185-194
Patanaphan, V.; Salazar, O.M. 1993: Colorectal cancer: metastatic patterns and prognosis Southern Medical Journal 86(1): 38-41
Blumberg, N.; Heal, J.M. 1993: Blood transfusions and prognosis in colorectal cancer New England Journal of Medicine 329(18): 1355; Author Reply 1355-1356
Zhang, S.; Yuan, W.; Tang, W.; Xu, C.; Ma, J. 2015: Expression of microRNA-100 and its relation with prognosis of colorectal cancer Zhonghua Zhong Liu Za Zhi 37(8): 603-608
Yu, J.-x.; Wu, Y.-l.; Yang, L.-t. 2005: The value of metastatic lymph nodes ratio in predicting the prognosis of patients with T3 gastric carcinoma Zhonghua Yi Xue Za Zhi 85(13): 922-925
Chayakulkeeree, M.; Thamlikitkul, V. 2003: Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever Journal of the Medical Association of Thailand 86(3): 212-223
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Ma, J.; Chang, W.; Zhang, W. 2018: Relationship between the expression of DDX39 protein and prognosis of colorectal cancer Zhonghua Wei Chang Wai Ke Za Zhi 21(3): 336-341
Yu, J.-W.; Wang, G.-Q.; Zhao, Y.-H.; Sun, L.-J.; Wang, S.-Q.; Li, S.-C. 2007: The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment Hepatobiliary and Pancreatic Diseases International: Hbpd Int 6(5): 492-496
Hedrick, T.L.; Swenson, B.R.; Friel, C.M. 2013: Model for End-stage Liver Disease (MELD) in predicting postoperative mortality of patients undergoing colorectal surgery American Surgeon 79(4): 347-352
Nishi, Y.; Takano, Y.; Kakita, A. 1994: Analyses of PCNA and AgNOR on advanced colorectal cancer as predictive indicators of the prognosis Nihon Geka Gakkai Zasshi 95(11): 797-806